Clinical Trial Update: Assessing the Safety and Effectiveness of Intracoronary Stem Cells in Patients With Refractory Angina [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the safety and effectiveness of intracoronary stem cells in patients with refractory angina and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina

Drugs mentioned

• intracoronary stem cells

Snippet

Sponsor: Barts & The London NHS Trust | Conditions: Refractory Angina Pectoris, Refractory Angina | Phase 2 | Status: RECRUITING